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Abstract
Background: TGF beta and its receptors are present in both germ cells and somatic cells of the
male gonad. However, knock-out strategies for studying spermatogenesis regulation by TGF beta
have been disappointing since TGF beta-or TGF beta receptor-null mice do not survive longer than
a few weeks.
Methods: In the present study, we addressed the role of TGF beta-1 on the completion of meiosis
by rat pachytene spermatocytes (PS) cocultured with Sertoli cells. Identification and counting of
meiotic cells were performed by cytology and cytometry.
Results: Under our culture conditions, some PS differentiated into round spermatids (RS). When
TGF beta-1 was added to the culture medium, neither the number of PS or of secondary
spermatocytes nor the half-life of RS was modified by the factor. By contrast, the number of RS and
the amount of TP1 mRNA were lower in TGF beta-1-treated cultures than in control cultures.
Very few metaphase I cells were ever observed both in control and TGF beta-1-treated wells.
Higher numbers of metaphase II were present and their number was enhanced by TGF beta-1
treatment. A TGF beta-like bioactivity was detected in control culture media, the concentration of
which increased with the time of culture.
Conclusion: These results indicate that TGF beta-1 did not change greatly, if any, the yield of the
first meiotic division but likely enhanced a bottleneck at the level of metaphase II. Taken together,
our results suggest strongly that TGF beta participates in an auto/paracrine pathway of regulation
of the meiotic differentiation of rat spermatocytes.
Background
Multiplication, differentiation and survival or death of
testicular germ cells are tightly regulated processes. Over
the last decades it has become obvious that, in addition to
the regulation exerted by the pituitary hormones (mainly
FSH and LH) [1], spermatogenesis is under the control of
a complex network of factors originating from both the
somatic cells and the germ cells of the testis [2,3].
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Moreover, it is becoming clear that hormones and intrat-
esticular factors may compensate at least in part, for the
absence of some hormones or factors, including FSH [4-6]
and androgen [7-10] or luteinizing hormone [11] recep-
tors. Thus, it is likely that synergism and/or redundancy
between regulatory molecules is a characteristic of the
spermatogenic process. Since most of the growth factors,
cytokines and neurotrophins produced within the testis
are widely expressed in the organism, the attempts to
understand their role in spermatogenesis by knock-out
strategies have been often disappointing. Transforming
growth factor (TGFβ ) is an example of such molecules.
TGFβ 1, TGFβ 2 and TGFβ 3 are expressed in the male
gonad and their receptors are present in the rat testis in
both somatic cells and germ cells [12-16]. TGFβ - or TGFβ
receptor-null mice have been created [17-23]. However, as
these mice do not survive longer than a few weeks, their
usefulness for studying spermatogenesis is limited. Hence,
use of culture systems associating spermatogenic cells and
testicular somatic cells might be a valuable alternative to
study the possible involvement of intratesticular factors
such as the TGFβ s on some step(s) of spermatogenesis.
We [24,25] and others [26-28] have demonstrated that
meiosis can proceed in vitro when mammalian sperma-
togenic cells are cocultured with Sertoli cells. In rodents,
the kinetic of the meiotic process is similar in vivo and dur-
ing the first week of culture [24,26,29] and round sperma-
tids developed in vitro can produce normal offspring [30].
Such culture systems have allowed to study some cellular
aspects of the meiotic process [31] or of its regulation
[32]. Hence, in the present work, we addressed the role of
TGFβ 1 on the completion of meiosis by rat pachytene
spermatocytes cultured together with Sertoli cells.
Methods
Isolation and co-culture of rat Sertoli cells and pachytene 
spermatocytes or round spermatids
Co-cultures of 21-day old rat Sertoli cells and adult rat
pachytene spermatocytes (PS) or round spermatids (RS)
were performed in bicameral chambers as described by
Weiss et al. [24]. More than 90% of the cells in the PS frac-
tion were 4C cells and more than 80% in the RS fraction
were 1C cells; moreover, we found previously that 13% of
elutriated PS were early PS (stages XIV-IV), 61% were mid-
dle PS (stages V-IX) and 26% were late spermatocytes
(stages X-XIII) [32]. In some experiments, adult rats were
injected with 5-bromo-2'-deoxyuridine (BrdU, Sigma-
Aldrich, St Quentin Fallavier, France) (50 mg/kg) 14 days
before they were killed, in order to label PS/diplotene
spermatocytes of stages VII-XIII [32]. Under these condi-
tions, BrdU-labelled stages XI, XII, and XIII (the only
stages containing spermatocytes which may have time to
differentiate into RS over a 3-day culture period
[24,26,29]) represented 18% of the total number of stages
containing BrdU-labelled PS/diplotene spermatocytes.
These procedures were approved by the Scientific
Research Agency (approval n° 69306) and conducted in
accordance with the guidelines for care and use of labora-
tory animals.
Cells were cultured in Dulbecco's Modified Eagle's
Medium (F12/DMEM) supplemented with antibiotics,
NaHCO3 (13.4 mM), insulin (10 µg/ml), transferrin (10
µg/ml), vitamin C (10-4M), vitamin E (10 µg/ml), testo-
sterone (10-7M), retinoic acid (3.3 × 10-7 M), retinol (3.3
× 10-7 M), pyruvate (1 mM) (all products from Sigma-
Aldrich, St Quentin Fallavier, France), and ovine NIH
FSH-20 (1 ng/ml) obtained through NIADDK at 33°C in
an humidified atmosphere of 95% air : 5% CO2. In
TGFβ 1-treated wells, human recombinant TGFβ 1 (10 ng/
ml) (R&D Systems, Lille, France) was added in both the
apical and the basal compartments of the bicameral
chamber. Only basal media (with or without 10 ng/ml
TGFβ 1) were renewed every two days; TGFβ 1 was added
to the apical media at the same interval.
Immunolabeling of cells for flow cytometry
At selected days of culture, cells were detached from cul-
ture wells by trypsinization. After counting and determi-
nation of cell viability by Trypan blue exclusion, cells were
fixed with ice cold 70% ethanol.
Immunolabeling of cultured cells and flow cytometric
analyses were performed as described by Vigier et al. [32]
and Godet et al. [33]. After washing with phosphate-buff-
ered saline (PBS), fixed cells were resuspended in perme-
abilizing buffer (0.25% Triton X-100/1% BSA/PBS) for 20
minutes on ice. The cells were then exposed to an anti-
vimentin antibody (clone V9 – Dako SA, Trappes, France)
at a dilution of 1:500 in blocking buffer (5% fetal calf
serum/1% BSA/PBS) for 3 h at 4°C. After 3 washes in 1%
BSA/PBS, the cells were incubated with fluorescein
(FITC)-conjugated rabbit anti-mouse immunoglobulins
(Dako SA, Trappes, France) diluted 1:60 in blocking
buffer for 1 hour at 4°C. Before analysis, Hoechst 33342
(Sigma-Aldrich, St Quentin Fallavier, France) was added
to the labeled cell suspension at a final concentration of
20 µg/ml.
Flow cytometric and computer analyses
After immunolabeling, cells were analysed using a FacsS-
tar plus Cytometer (Becton Dickinson, Le Pont de Claix,
France) equipped with a 50-mW argon laser tuned to 448
nm and an INNOVA 300 ion multilined/UV laser tuned to
UV. Emission of fluorescence was measured with a DF
530/30 filter for FITC, and a DF 42/44 filter for Hoechst
33342. Data acquisition and analysis were performed
with CellQuest software (Becton Dickinson, Le Pont de
Claix, France). Four data parameters were acquired and
stored in list mode files: linear forward light scatter (FSC)Reproductive Biology and Endocrinology 2005, 3:22 http://www.rbej.com/content/3/1/22
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and linear side angle light scatter (SSC) which roughly
represent cell size and cellular granularity, respectively;
logarithmic FITC (vimentin) to detect immunolabeling,
and linear Hoechst to measure the DNA content of the dif-
ferent cell populations. Contaminating events such as
debris and clumped cells were eliminated from the analy-
sis. Each acquisition was performed on 50 000 cells nega-
tive for vimentin and allowed to identify 1C, 2C and 4C
germ cells. Hence, the percentage of each category of germ
cells was multiplied by the total number of cells per well
in order to obtain the absolute number 1C, 2C and 4C
cells.
RNA extraction
Total RNA from cultured cells was extracted according to
Chomczynski and Sacchi [34], using Trizol Reagent (Inv-
itrogen, Cergy-Pontoise, France). The purity and the integ-
rity of the RNA were checked spectroscopically and by gel
electrophoresis respectively.
Reverse transcription-polymerase chain reaction (RT-
PCR)
Sequences corresponding to TP1 mRNA [EMBL: X07284]
or p21 mRNA [EMBL: NM080782] and 16S rRNA [EMBL:
XM341815] were amplified by RT-PCR as follows. Single
strand cDNAs were obtained from reverse transcription
(RT) of 1 µg of total RNA in a final volume of 10 µl con-
taining 100 IU of Moloney murine leukaemia virus
reverse transcriptase (MMLVRT), 1.25 mM dNTPs, 0.4 µg
of oligo-dT, 10 mM DTT and 15 IU of RNase Guard (all
products from Invitrogen, Cergy-Pontoise, France). RT
was performed for 1 hour at 37°C. A sample in which
RNA was replaced by sterile water was used as a negative
control.
TP1/16S
coamplification reactions were carried out on 80 ng of
reverse-transcribed RNA in a final volume of 30 µl con-
taining 1,5 IU of Taq DNA Polymerase (Roche Diagnostic,
Mannheim, Germany), 2 µM dNTPs, 1 µCi [33P]dATP
(Amersham Biosciences, Orsay, France) and 12.5 pmol of
each of the sequence-specific primers for TP1 and 16S
(Sigma-Aldrich, St Quentin Fallavier, France) (Table 1).
Amplification was performed in 5 sequential cycles (16,
18, 19, 20 and 22 cycles) at 94°C for 1 minute, 58°C for
1 minute and 72°C for 1 minute.
p21/16S
coamplification reactions were carried out on 80 ng of
reverse-transcribed RNA in a final volume of 30 µl con-
taining 1,5 IU of Taq DNA Polymerase (Roche Diagnos-
tics), 3 µM dNTPs, 1.5 µCi [33P]dATP (Amersham
Biosciences) and 12.5 pmol of the sequence-specific prim-
ers for p21 (Sigma-Aldrich) (Table 1). In a first step,
amplification was performed for 6 cycles at 94°C for 1
minute, 58°C for 1 minute and 72°C for 1 minute. Then,
12.5 pmol of the sequence-specific primers for 16S were
added and amplification was continued and performed in
5 sequential cycles (20, 22, 24, 26 28 cycles).
The amplified products were electrophoresed in parallel
with size markers on 3% Metaphor Agarose gels (Tebu, Le
Perray-en-Yvelines, France). The bands were cut from the
gels and melted in distilled water at 100°C. Radioactivity
was measured using a liquid scintillation counter.
TGFβ  bioassay
TGFβ  concentrations in apical culture media were deter-
mined using mink lung epithelial cell (CCl-64), according
to Danielpour et al. [35]. Briefly, CCl-64 cells were main-
tained in 75 cm2 flasks in F-12 DMEM medium supple-
mented with 10% foetal calf serum. In 0.32-cm2 wells (96-
well plate), aliquots (5–10 µl) of conditioned medium
heated (or not) at 80°C for 5 minutes were added in 100
µl assay medium supplemented with 5% foetal calf
serum. After 1 hour at 37°C, CCl-64 cells in logarithmic
growth phase were trypsinised, washed once with assay
medium, and plated at 3.104 cells/100 µl in wells. CCl-64
Table 1: Sequences of the primers used to amplify mRNAs for TP1, p21 and 16S RNA
RNA Primers Product size(nt)
TP1 [EMBL: X07284]* 5'26 – CCAGCCGCAAACTAAAGACTCATGG – 3' 175
5'200 – AGCTCATTGCCGCATTACAAGTGGG – 3'
p21 [EMBL: NM080782]* 5'107 – GACCTGTTCCACACAGGAGCAAAGT – 3' 145
5'251 – GTCTCAGTGGCGAAGTCAAAGTTCC – 3'
16S [EMBL: XM341815]* 5'138 – TGGGCTCATCAAGGTGAATGG – 3' 268
5'405 – GGTCCGATCGTACTGGATGAGGATA – 3'
nt : nucleotides
* gene bank accession numbers.Reproductive Biology and Endocrinology 2005, 3:22 http://www.rbej.com/content/3/1/22
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cells were cultured overnight, followed by pulse labelling
with [3H]thymidine (40–60 Ci/mmol; Amersham Bio-
sciences, Orsay, France) at a final concentration of 1 µCi/
ml for 4 hours at 37°C. The cells were fixed three times
with 250 µl methanol-acetic acid (3:1, vol/vol) and were
washed twice with 80% methanol. 3H-labeled DNA was
extracted by 250 µl 0.4% deoxycholate 0.5 N NaOH. Radi-
oactivity was measured by a liquid scintillation counter.
In some cases TGFβ  bioactivity of culture media was deter-
mined in the presence of a TGFβ 1/2/3 blocking antibody
(clone 1D11, R&D Systems, Lille, France).
Immunocytochemical studies on cultured cells
At selected days of culture, cells were fixed directly in the
well with Bouin's fixative for 20 minutes at room
temperature.
1-Immunocytochemical reaction against phosphorylated Histone H3 
(pH3)
After washing with PBS, fixed cells were permeabilized
with 0.03% TritonX-100 in PBS for 30 minutes. The
immunocytochemical reaction was performed with the
Dako LSAB kit (Dako SA, Trappes, France) as follows.
Cells were incubated with 3% H2O2 for 5 minutes, rinsed
with PBS, then incubated with a monoclonal mouse anti-
pH3 antibody (Upstate Biotechnology, Euromedex, Mun-
dolsheim, France) at 1:200 dilution in Dako's antibody
diluent for 3 hours at room temperature. After three
washes with PBS, the staining reaction was performed
using the avidin-biotin-peroxydase complex and amino-
3-ethyl-9-carbazole (AEC) as a chromogen.
2-BrdU immunochemical reaction
The same protocol as described above was performed, but
denaturation of DNA was required before the immunore-
action. Cells were incubated for 5 minutes with NaOH
0,07N diluted in alcohol:water (v:v) and then dipped in
PBS for 10 minutes. Cells were incubated with a mono-
clonal mouse anti-bromodeoxyuridine antibody (Dako
SA, Trappes, France) diluted 1:100 overnight at 4°C. After
three washes with PBS, the staining reaction was per-
formed using avidin-biotin-peroxidase complex and AEC
as a chromogen.
The membrane of the insert was cut off and mounted in
Dako aqueous mounting medium.
The morphologic identification and counting of the dif-
ferent types of germ cells was performed as previously
described [32].
Statistical analysis
ANOVA was used to compare between data from more
than two groups. Paired Student's t test was used to assess
statistical differences between control and TGFβ 1-treated
cells.
Results
Effects of TGFβ 1 on the number and viability of total germ 
cells and somatic cells
When about 3.105 purified PS were cocultured with about
3.105 Sertoli cells, both the number of total cells (somatic
cells plus germ cells) and their viability decreased slightly
during the culture period, as expected [24]. For both
parameters, the decreases were similar in control and
TGFβ 1-treated cultures. On day 7, the percentages of cells,
compared with day 1, were 79 ± 8 and 79 ± 10% (m ±
SEM, n = 7) for controls and treated cells; the viabilities
were 71 ± 4 and 69 ± 3%, respectively. Every day they were
studied, the percentages of germinal cells and of somatic
cells were similar in control and TGFβ 1-treated cultures
but the percentage of germ cells decreased during the cul-
ture, whereas that of somatic cells increased 1.3 fold (data
not shown). This indicates that germinal cells were lost at
a similar rate irrespective the culture conditions, whereas
the number of somatic cells remained constant during the
culture period.
Effects of TGFβ 1 on the number of germ cells of different 
ploidy and on the amount of TP1 mRNA
The number of seeded PS (4C cells) decreased 2.5 fold
between day 1 and day 7 in control and TGFβ 1-treated
cultures (both p < 0.01) and no difference was observed
between these two conditions on any studied day (Fig. 1).
Under our culture conditions, some of the PS differenti-
ated into RS (1C cells) [24,31,32]. However, when TGFβ 1
was added to the culture medium, the number of in vitro
formed RS was significantly lower on days 5 and 7 than in
control cultures (p < 0.01 and p < 0.05 respectively). By
contrast, no significant difference was ever observed in the
population composed of secondary spermatocytes and of
doublets of RS (2C cells) (Fig. 1). In addition, the amount
of TP1 mRNAs (specific to the haploid state), assessed by
the TP1/16S ratio on day 14, of TGFβ 1-treated cultures
was lower than that of controls (p < 0.05) (Fig. 2).
Effects of TGFβ 1 on the survival of RS cultured with Sertoli 
cells
Taken together, these results suggest that TGFβ 1 inhibited
the differentiation of PS into RS and/or affected the sur-
vival of RS. Therefore, in the next series of experiments,
purified RS were cocultured with Sertoli cells for 5 days
either in the absence or presence of TGFβ 1 and the
number of RS was determined daily between days 2 and
5. As expected [24,32], there was a steady decrease in the
number of RS during the culture period. The regression
line fitting the number of remaining RS on each day
allowed the calculation of the half-life of RS which was
identical in the absence or presence of TGFβ 1 (Table 2).Reproductive Biology and Endocrinology 2005, 3:22 http://www.rbej.com/content/3/1/22
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Effects of TGFβ 1 on the number of BrdU-labeled meiotic 
germ cells and the number of meiotic metaphases
Hence, the above results indicate that most likely, TGFβ 1
was able to inhibit, at least partly, some step(s) in the dif-
ferentiating pathway of PS into RS. In an attempt to iden-
tify this step, in the next experiments, BrdU-labeled PS/
diplotene spermatocytes of stages VII-XIII were cocultured
with Sertoli cells in the absence or presence of TGFβ 1 ;
then, the number of BrdU-labeled PS, BrdU-labeled sec-
ondary spermatocytes (SII) and that of BrdU-labeled RS
were assessed by microscopic examination. The data pre-
sented in Table 3 show that TGFβ 1 treatment modified
Changes in the number of germ cells of different ploidy in  cocultures of Sertoli cells and PS (4C cells) maintained in the  absence (control) or presence of 10 ng/ml TGFβ 1 (TGFβ 1) Figure 1
Changes in the number of germ cells of different ploidy in 
cocultures of Sertoli cells and PS (4C cells) maintained in the 
absence (control) or presence of 10 ng/ml TGFβ 1 (TGFβ 1). 
Results are the mean ± SEM of seven experiments. ** p < 
0.01 vs control; * p < 0.05 vs control.
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Effect of TGFβ 1 on the TP1 mRNA/16S rRNA ratio on day  14 of cocultures of Sertoli cells and PS Figure 2
Effect of TGFβ 1 on the TP1 mRNA/16S rRNA ratio on day 
14 of cocultures of Sertoli cells and PS. PS were cocultured 
with Sertoli cells for 14 days either in the absence (control) 
or presence of 10 ng/ml TGFβ 1. On day 14 of coculture, 
total RNA was extracted and TP1 mRNA and 16S rRNA 
were coamplified by RT-PCR, as described in the Materials 
and Methods section, and their ratio were calculated. Each 
point is the mean ± SEM of four experiments. * p < 0.05 vs 
control.
Table 2: Half-lives of RS cocultured with Sertoli cells in the 
absence or presence of TGFβ 1
Treatment Half-life (days)
Control 1.9 ± 0.2
TGFβ 1 1.9 ± 0.2
Elutriated RS were cocultured with Sertoli cells for 5 days in the 
absence (control) or presence of 10 ng/ml TGFβ 1 and the number of 
remaining RS was assessed by flow cytometry daily between day 2 and 
day 5 allowing the determination of their half-life in culture. Each 
value is the mean ± SEM of three different experiments.
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neither the number of PS nor the number of SII on any
studied day, but decreased the number of RS on day 3 of
culture. In addition, the number of metaphases seemed to
increase a little on day 3 in the presence of TGFβ 1.
Therefore in the next experiments, cultured cells were
stained with a Ser 10 phosphorylated histone H3 anti-
body in order to label cells in the division phase [36,37]
and the numbers of metaphase I and metaphase II were
recorded at the level of the whole germ cell population,
not only BrdU-labelled cells (Fig. 3 and Table 4). Very few
meiotic metaphase I cells were ever observed both in con-
trol and in TGFβ 1-treated cultures precluding meaningful
statistical analysis. By contrast, higher numbers of
metaphases II were present on any studied day. Further-
more, the number of metaphase II was significantly
enhanced over control by TGFβ 1 on days 3 and 5 of the
experiment (p < 001 and p < 0.05 respectively).
Effects of TGFβ 1 on the expression of p21 mRNA
In an attempt to explore the mechanism of this inhibitory
effect of TGFβ 1 on the cell cycle of the meiotic cells, in the
following experiments the amount of mRNA encoding for
the cyclin-dependent kinase inhibitor p21waf1/cip1  was
assessed on days 1, 2, and 3 of cocultures performed in the
absence or presence of TGFβ 1. The p21/16S ratio was sim-
ilar in control and TGFβ 1-treated cultures on any tested
day (data not shown).
Changes in the concentration of TGFβ  bioactivity during 
coculture of PS with Sertoli cells
Secretion of TGFβ 1 by Sertoli cell-germ cell cocultures has
been demonstrated by western blotting [38]. Therefore in
the following experiments we studied whether a TGFβ -
like bioactivity was released under our culture conditions.
No TGFβ -like bioactivity could be detected in the media
of the apical compartments of the culture chambers prior
heat-treatment (data not shown). By contrast significant
amounts were observed following heat activation; the
concentration increased almost linearly with the time of
culture from 0.8 ± 0.1 on day 3, up to 4.0 ± 0.2 ng/ml on
day 15 (m ± SEM, n = 3). This bioactivity was completely
blocked by a TGFβ  neutralizing antibody directed against
TGFβ 1,2,3 (data not shown).
Table 3: Numbers of BrdU-labeled PS, of BrdU-labeled secondary spermatocytes (SII) and BrdU-labeled RS on day 1 and day 3 of 
coculture of BrdU-labeled PS/diplotene spermatocytes of stages VII-XIII and Sertoli cells in the absence or presence of TGFβ 1
Number of PS/mm Number of SII/mm Number of RS/mm Number of metaphases
Days of culture - + - + - + - +
1 (n = 3) 67.6 ± 14.5 NS 63.9 ± 17.4 1.3 ± 0.3 NS 1.7 ± 0.3 0.1 ± 0.1 NS 0.1 ± 0.1 0 NS 0
3 (n = 7) 42.7 ± 5.1 NS 33.4 ± 6.1 4.1 ± 0.8 NS 3.8 ± 0. 9 5.7 ± 1.3 p < 0.05 4.2 ± 1.3 1.3 ± 0.2 NS 1.8 ± 0.3
BrdU-labeled PS/diplotene spermatocytes were cocultured for 3 days in the absence (-) or presence (+) of 10 ng/ml TGFβ 1. On days 1 and 3, the 
numbers of BrdU-labeled PS, BrdU-labeled SII, BrdU-labeled RS and BrdU-labeled metaphases were determined by microscopic examination of the 
culture wells and expressed as the number of each cell type per mm of well and on the width of the microscope field (objective × 100). About 500 
BrdU-labeled cells were counted in each condition and in each experiment.
Each value is the mean ± SEM ; n : number of experiments.
NS : not significant.
Table 4: Numbers of metaphase I and metaphase II on different days of coculture of PS and Sertoli cellsin the absence or presence of 
TGFβ 1
Number of metaphases I/mm Number of metaphases II/mm
Days of 
coculture
Control TGFβ 1 Control TGFβ 1
1 0.09 ± 0.02 NT 0.03 ± 0.01 1.8 ± 0.3 NS 1.8 ± 0.3
3 0.15 ± 0.04 NT 0.05 ± 0.03 2.3 ± 0.3 p < 0.01 3.1 ± 0.4
5 0.04 ± 0.02 NT 0.03 ± 0.01 0.7 ± 0.1 p < 0.05 0.9 ± 0.2
PS were cocultured for 5 days in the absence (control) or presence of 10 ng/ml TGFβ 1. On days 1, 3 and 5, the numbers of metaphase I and of 
metaphase II were determined by microscopic examination of the culture wells and expressed as the number of each type per mm of well and on 
the width of the microscope field (objective × 100). 400 to 1700 metaphase II were counted in each condition, whereas the number of metaphase I 
which could be counted ranged between 15 and 75 precluding meaningful statistical analysis.
Each value is the mean ± SEM of 5 different experiments.
NS : not significant ; NT : not tested.Reproductive Biology and Endocrinology 2005, 3:22 http://www.rbej.com/content/3/1/22
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Discussion
To our knowledge, there has been no previous study on
the effect of TGFβ  on the meiotic differentiation of male
germ cells. Yet it has been shown that germ cells synthe-
size TGFβ  and are targets for the peptide (see [39] for
review). However, TGFβ -null mice die in pre-or neonatal
stages, making it virtually impossible to investigate the
significance of TGFβ  in the late stages of spermatogenesis
[17-23]; hence we have studied the effect of TGFβ  on mei-
otic differentiation of spermatogenic cells by using a sys-
tem of culture of rat PS previously established in our
laboratory [24,31,32]. No effect of TGFβ 1 was observed
on the number of remaining PS or Sertoli cells on any day
under our culture conditions. Likewise TGFβ 1 did not
modify the half-life of seeded RS. Hence, it seems reason-
able to conclude that the lower number of RS observed in
TGFβ 1-treated wells was due to an inhibitory effect of this
factor on the transformation of PS into RS. This assump-
tion appears substantiated by the lower content in TP1
mRNAs (specific to the haploid state) of TGFβ 1-treated
cultures of 14 days. Screening of TP1 mRNA content was
performed on day 14 for two reasons : i) the total number
of RS in TGFβ 1-treated cultures was significantly lower
than in controls only from day 5 onward (Fig. 1). ii) We
showed previously that expression of TP1 appears to be
important only from steps 5–6 of spermiogenesis, that is,
4–5 days after completion of meiosis [40]. However, the
possibility that TGFβ 1 might decrease the transcription of
TP1 and/or the half-life of its mRNA cannot be excluded.
An effect of TGFβ 1 was observed only beyond one day of
culture, which is the time necessary to the more advanced
elutriated spermatocytes (stage XIII) to differentiate into
secondary spermatocytes under our culture conditions
[31], and affected the 1C-cell population but not the 2C-
cell population. Moreover, cytological monitoring of the
fate of BrdU-labeled PS showed that the numbers of SII
were similar in the absence or presence of TGFβ 1, whereas
the number of BrdU-labeled metaphase seemed enhanced
by this factor. This latter point was confirmed, at the level
of the whole germ cell population, by use of a Ser 10
phosphorylated histone H3 antibody which allowed us to
show that the number of second metaphases was
enhanced in the presence of TGFβ 1. Taken together, these
results suggest that TGFβ 1 did not change greatly, if any,
the yield of the first meiotic division, but likely enhanced
a bottleneck resulting in an increase in the number of met-
aphase II.
Progression of cells through the cell cycle requires assem-
bly and activation of cyclin-CDK complexes [41]. CDK
activity can be regulated by changes in cyclin or CDK lev-
els, by post-translational modifications of the CDK subu-
nit and by formation of a complex with a set of proteins
Staining of metaphase I (left) and metaphase II (right) by a Ser 10 phosphorylated histone H3 antibody in cocultures of PS and  Sertoli cells (day one of coculture; bars represent 10 µm) Figure 3
Staining of metaphase I (left) and metaphase II (right) by a Ser 10 phosphorylated histone H3 antibody in cocultures of PS and 
Sertoli cells (day one of coculture; bars represent 10 µm).
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called CKI [42]. P21waf1/cip1 belongs to the CKI family and
binds to CDK2-cyclin A/E complexes [43] which are active
during the G1 phase, S phase and/or the G2/M transition.
Moreover, CDK2 and cyclin A1 appear essential for meio-
sis [44-46]. Several studies have shown that TGFβ 1
induces p21waf1/cip1  expression [47,48]. In the testis,
Beumer et al. [49] have suggested that p21waf1/cip1 could be
important during the meiotic phase of spermatocytes as it
is present in PS of stage V up to step 5 RS. As the work
stands, we did not observe an increase in the amount of
p21waf1/cip1 mRNA in TGFβ 1-treated cultures. However,
additional mechanisms appear able to mediate the cell
cycle arrest caused by TGFβ  [43,50-52].
In vivo, TGFβ 1 is present mainly in spermatocytes and RS
[13,53] and rat testicular germ cells and Sertoli cells
release different types of bioactive TGFβ s  in vitro (
[12,38,53] and present results).
Immunohistochemistry studies have localized both type I
(Tβ RI) and type II (Tβ RII) transducing receptors for TGFβ
to the seminiferous epithelium in the rat testis [12,15,16].
Moreover, Smad2 and Smad3 that mediate intracellular
signaling of the TGFβ  superfamily from the cell surface to
the nucleus are present in meiotic cells [54,55] and TGFβ
can regulate gene expression in these cells [56]. The
amounts of TGFβ -like bioactivity measured in our culture
media fit quite well with those reported in cell culture
supernatants of different testicular cell types by Haagmans
et al. [53]. Moreover, these concentrations are quite in the
range of the TGFβ  concentrations required to regulate
Cyp19 gene expression in isolated rat PS and RS [56] or to
perturb the inter-Sertoli tight junction permeability bar-
rier in vitro [57]. Furthermore, the work of Haagmans et al.
[53] indicates that latent TGFβ  released by primary cul-
tures of germ cells and Sertoli cells can be converted into
a bioactive form in the culture medium. Taken together,
these results strongly suggest that TGFβ  can be involved in
an auto/paracrine pathway of regulation of the meiotic
differentiation of rat spermatocytes. In experiments not
reported here, we tried to inhibit the meiotic action of
"endogenous" TGFβ  with the anti-TGFβ  antibody we used
in the above bioassay ; however, the acid wash required to
remove the antibody before counting the germ cells by
either method precluded accurate analyses.
It might be argued that the effects of TGFβ 1 observed in
the present study are relatively minor. However, it must be
underlined that their amplitude is quite similar to the
effects of TGFβ  on [3H]thymidine incorporation by rat
seminiferous tubule segments [58] or on the reduction of
the number of rat gonocytes [59]. Moreover, it must be
emphasized that the rather high standard errors of means,
both in control and TGFβ 1-treated cultures, were much
more due to variations between the different experiments,
as occurs often in vitro, than to variations of the effect of
TGFβ 1 treatments. Indeed, for instance, of the seven
experiments reported in Fig. 1 or in Table 3 (day 3), six or
seven exhibited a lower number of RS in TGFβ 1-treated
wells vs controls. Therefore it is not surprising that statis-
tical analysis resulted in significant differences. In addi-
tion, it is clear that synergism and/or redundancy between
local regulatory factors are a characteristic of the sperma-
togenic process ([2,32] and unpublished results). Hence it
is not unexpected that many regulatory molecules, pro-
duced within the testis, may have somewhat limited effect
when tested in the presence of the other factors regulating,
in the same sense, the same step of spermatogenesis. As
for the effects of TGFβ 1 observed in the present work, two
points should be emphasized: i)it is most likely that the
amplitude of the effects of exogenous (added) TGFβ 1
were limited by the TGFβ  produced by our germ cell-Ser-
toli cell cocultures (see above); ii) in other studies not
reported here, we observed that NGF, which is produced
by PS and RS both in vivo  [60, 61] and under our culture
conditions (M.H. Perrard, unpublished results) is also
able to negatively regulate the meiotic divisions of rat PS.
Thus, it is very likely, that the presence of endogenous
NGF also limited the effects of TGFβ 1 observed in the
present studies. Indeed, such a synergism/redundancy
appears to be a major problem when exploring the local
regulations of spermatogenesis which makes the knowl-
edge of this topic far from being complete. Additional
studies are now required to understand the mechanism of
this action of TGFβ 1 and why it is likely to be on the sec-
ond meiotic division.
Conclusion
These in vitro results, together with previous studies show-
ing the presence of TGFβ  and its receptors in both the
germ cells and the somatic cells of the male gonad, suggest
strongly that TGFβ 1 participates in an auto/paracrine
pathway of regulation of the meiotic differentiation of rat
spermatocytes.
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